Skip to main content

Incyte Signs Lease on its First East Coast R&D Site

SAN FRANCISCO, March 4 - Incyte Genomics has leased space in Delawarefor its first East Coast research site, the company said on Monday.


The 50,000 square foot lab, leased from Dupont at its Newark, Del., Stine-HaskellResearchCenter, is scheduled for occupancy in March.


Financial details of the lease agreement were not disclosed.


The lab will support approximately 80 new R&D positions in 2002, with 140 new positions projected by 2004 and 200 by 2005, according to Incyte.


"Our success in attracting Incyte to Delawareis part of my administration's overall strategy to build and strengthen Delaware's offerings as a hub for biotechnology," Governor Ruth Ann Minner said in a statement.


Nearby Maryland also has its sights set on attracting biotech companies, GenomeWeb reported in November.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.